Compare Biogen Inc (BIIB) vs Fox Corp Class B (FOX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Biogen Inc vs Fox Corp Class B — how do they compare? Biogen Inc trades at $202.7 (market cap $30.13B), while Fox Corp Class B trades at $55.42 (market cap $24.58B). The key difference: Biogen Inc is the larger of the two by market cap, and Fox Corp Class B pays a 1.05% dividend while Biogen Inc pays none. Which is the better fit depends on your goals.
| BIIB | FOX | |
|---|---|---|
Market Cap | $30.13B | $24.58B |
Sector | Health | Media |
52-Week High | $216.63 | $67.76 |
52-Week Low | $128.93 | $44.39 |
Enterprise Value | $37.20B | $27.94B |
Dividend Yield | — | 1.05% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Biogen Inc
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.
Read more on BIIB →About Fox Corp Class B
Fox represents the assets not sold to Disney by the predecessor firm, Twenty First Century Fox. The remaining assets include Fox News, the FOX broadcast network, FS1 and FS2, Fox Business, Big Ten Network, 28 owned and operated local television stations of which 17 are affiliated with the Fox Network, and the Fox Studios lot. The Murdoch family continues to control the successor firm, which represents a large-scale bet on the value of live sports and news in the U.S. market.
Read more on FOX →
